Torunn Berge
Papers
1
Total Citations
154
H-Index
1
About
Torunn Berge is a leading molecular biologist whose work has fundamentally advanced our understanding of cellular signaling, particularly the intricate mechanisms of the cAMP pathway. Her research focuses on the spatial and temporal control of protein kinase A (PKA), a critical enzyme involved in everything from metabolism to memory. Berge’s major contribution lies in elucidating the role of A-kinase anchoring proteins (AKAPs), which act as molecular scaffolds to position PKA at precise subcellular locations. Her seminal 2006 paper, cited over 150 times, introduced a novel tool—a disruptor peptide that specifically targets Type I PKA signaling. This work was pivotal in demonstrating that different PKA isoforms have distinct, non-redundant functions, a concept that has reshaped the field. By providing a method to selectively block RI-anchored signaling events, Berge enabled researchers to dissect the specific roles of these complexes in health and disease. Her findings have profound implications for drug development, suggesting that targeting AKAP-PKA interactions could offer a new therapeutic strategy for conditions like cardiac hypertrophy and cancer.
Research Focus
Key Achievements
Top Papers
- 1